Document is current
Any future updates will be listed below
-
Authors
Verhulst, Clementine E. M.
van Heck, Julia I. P.
Fabricius, Therese W.
Stienstra, Rinke
Teerenstra, Steven
McCrimmon, Rory J.
Tack, Cees J.
Pedersen-Bjergaard, Ulrik
de Galan, Bastiaan E.
,
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (JU) . (No 777460, No 777460, No 777460, No 777460, No 777460, No 777460, No 777460, No 777460)
- License Information
-
More Information
Article History
Received: 18 October 2023
Accepted: 12 December 2023
First Online: 8 February 2024
Declarations
:
: C.E.M.V.: None. J.I.P.v.H.: None. T.W.F.: None. R.S.: None. S.T.: None. C.J.T.: None. B.E.d.G. has received research support from Novo Nordisk. U.P.-B. has served on advisory boards for Sanofi-Aventis and Novo Nordisk and has received lecture fees from Abbott, Sanofi-Aventis and Novo Nordisk. R.J.M. has received lecture fees from Sanofi-Aventis and Novo Nordisk.
